Crispr Therapeutics shares tumble after significant earnings miss
In a recent filing with the Securities and Exchange Commission, TriMas Corp (NASDAQ:TRS), a $831.55 million market cap company trading at a P/E ratio of 34.99, disclosed that Teresa Finley, a director at the company, has purchased a significant amount of the company’s common stock. On February 28, 2025, Finley acquired 14,388 shares at a price of $21.1194 per share. This transaction, totaling approximately $303,865, increases her total holdings to 54,351 shares following the purchase. This move may indicate confidence in the company’s future prospects, particularly noteworthy as InvestingPro data shows strong financial health with a current ratio of 2.68. According to InvestingPro, the company has 8 key investment insights available, including management’s aggressive share buybacks and expected net income growth. Get the full analysis with InvestingPro’s comprehensive research report, available for 1,400+ US stocks.
In other recent news, TriMas Corp. reported fourth-quarter earnings that exceeded analyst expectations, posting an adjusted earnings per share of $0.43, surpassing the consensus estimate of $0.39. The company’s revenue for the quarter rose by 8.8% year-over-year to $228.1 million, beating the expected $222.08 million. TriMas experienced strong growth in its Aerospace and Packaging (NYSE:PKG) segments, with Aerospace sales increasing by 22.3% year-over-year to $78.3 million and Packaging sales rising by 8.4% to $123.1 million. However, the Specialty Products segment saw a decline of 16.8%, with sales totaling $26.6 million.
For the full year 2024, TriMas reported adjusted earnings per share of $1.65 on revenue of $925 million, marking a 3.5% increase from 2023. Despite these strong results, the company provided guidance for 2025 that disappointed investors, forecasting full-year adjusted earnings per share between $1.70 and $1.85, below the analyst consensus of $2.01. The company anticipates 2025 sales to grow by 4% to 6% compared to 2024. TriMas President and CEO Thomas Amato noted that cost restructuring actions within Norris Cylinder are expected to improve performance as the cylinder market recovers. Additionally, the company repurchased 771,067 shares for $19.3 million in 2024 and paid a quarterly dividend of $0.04 per share.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.